Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 196 AL 210

Bile acids in Alzheimer's disease: a double-edged sword in gut-liver-brain signaling and neurodegeneration

Basri R, Al-Kuraishy HM, Alruwaili M, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Faheem SA, Batiha GE.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):16841-16859. doi: 10.1007/s00210-026-05516-1. Epub 2026 Jun 9.

The Innate Immune Protein IFITM3 as a γ-Secretase Modulatory Protein: From Inflammation to Alzheimer's Disease

Choi JS, Hur JY.

DNA Cell Biol. 2026 Aug;45(8):381-388. doi: 10.1177/10445498261456523. Epub 2026 Jun 9.

The relationship between Porphyromonas gingivalis infection and the development of Alzheimer's disease: A scoping review

Lopes Cardoso I, Guimarães MI, Tubiana E, Gavinha S.

J Alzheimers Dis. 2026 Aug;112(3):1114-1126. doi: 10.1177/13872877261456716. Epub 2026 Jun 9.

Splenic treg-related immunoregulation in the spleen-brain axis of alzheimer's disease: mechanisms and translational strategies

Zhang M, Shi L, Dong Y, Sun Y, Zhu S, Jin Q.

Mol Biol Rep. 2026 Jun 9;53(1):912. doi: 10.1007/s11033-026-12088-z.

Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology

Lohnes BJ, Myskova A, Tyagi A, Hartwig UF, Poddar NK.

Biosci Rep. 2026 Jun 17;46(6):BSR20260203. doi: 10.1042/BSR20260203.

A lifespan staging model of basal forebrain cholinergic vulnerability

Shanks HRC, Chen S, Onuska KM, Schmitz TW.

Alzheimers Dement. 2026 Jun;22(6):e71380. doi: 10.1002/alz.71380.

Advances in anti-tau therapeutics for alzheimer's disease: immunotherapy, gene modulation, and combination approaches

Mishra H, Mishra MK.

Mol Biol Rep. 2026 Jun 10;53(1):921. doi: 10.1007/s11033-026-12108-y.

Mitochondrial enzyme dysfunction in Alzheimer's disease: a systematic review of human metabolic evidence

Asadi Anar M, Fathollahi MA, Zare F, Farrokhi Z, Habibzadeh E, Hasany S, Mirmazloumi M, Arab Bafrani M, Abedian Kenari F, Falahati M, Khorsand K, Zakavi A, Asadollah Salmanpour Y, Yadegarifard E, Khosravi F, Goudarzi P.

Metab Brain Dis. 2026 Jun 10;41(1):132. doi: 10.1007/s11011-026-01895-9.

Alternative splicing in Alzheimer's disease: Driver, modifier, or consequence of neurodegeneration

Aranda-Abreu GE, Rojas-Durán F, Hernández-Aguilar ME, Herrera-Covarrubias D, Tlapa-Monge LR, Mestizo-Gutiérrez SL.

Mech Ageing Dev. 2026 Aug;232:112211. doi: 10.1016/j.mad.2026.112211. Epub 2026 Jun 10.

Sex differences in brain glucose metabolism and Alzheimer's disease risk and progression

Ramezan M, Demetriou A, Burke SN, Nalvarte I, Shin AC.

Alzheimers Dement. 2026 Jun;22(6):e71491. doi: 10.1002/alz.71491.

Gut-brain axis in Alzheimer's disease: neural and immune circuits linking peripheral dysbiosis to neurodegeneration

Mook-Jung I.

Curr Opin Neurobiol. 2026 Aug;99:103234. doi: 10.1016/j.conb.2026.103234. Epub 2026 Jun 11.

Meningeal lymphatic dysfunction in Alzheimer's disease: molecular mechanisms, clinical implications, and future perspectives

Liu L, Li JH, Bai YD, Wang YJ, Bu XL.

Mol Neurodegener. 2026 Jun 11;21(1):47. doi: 10.1186/s13024-026-00962-0.

Multi-Dimensional Transcriptomics Reveals the Prominent Role of Neuroinflammation in Alzheimer's Disease

Wang X, Rong Z, Xue F.

Int J Mol Sci. 2026 Jun 2;27(11):5020. doi: 10.3390/ijms27115020.

Beyond the Amyloid Hypothesis: Systemic Drivers, CNS-PNS Crosstalk, and the Future of Alzheimer's Disease Therapeutics

Velázquez de Castro-Bono A, Castro-Luna G, Guil-Guerrero JL.

Int J Mol Sci. 2026 Jun 2;27(11):5042. doi: 10.3390/ijms27115042.

SGLT2 Inhibitors in Alzheimer's Disease: Biochemical Insights and Therapeutic Potential

Mazzeo P, Vietri M, Tecce N, Delizia A, Remondelli V, Ciaglia T, Di Dio A, Corletti L, Pizzuti CG, Pepe G, Stabile E, Correale M, Campiglia P, Miranda MR, Tecce MF, Vestuto V.

Int J Mol Sci. 2026 Jun 3;27(11):5051. doi: 10.3390/ijms27115051.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias